Literature DB >> 30168635

Relationship between changing patient-reported outcomes and subsequent clinical events in patients with chronic heart failure: insights from HF-ACTION.

Nancy Luo1,2, Christopher M O'Connor1,3, Lauren B Cooper1,3, Jie-Lena Sun2, Adrian Coles2, Shelby D Reed2, David J Whellan4, Ileana L Piña5, William E Kraus1,2, Robert J Mentz1,2.   

Abstract

AIMS: A 5-point change in the Kansas City Cardiomyopathy Questionnaire (KCCQ) is commonly considered to be a clinically significant difference in health status in patients with heart failure. We evaluated how the magnitude of change relates to subsequent clinical outcomes. METHODS AND
RESULTS: Using data from the HF-ACTION trial of exercise training in chronic heart failure (n = 2331), we used multivariable Cox regression with piecewise linear splines to examine the relationship between change in KCCQ overall summary score from baseline to 3 months (range 0-100; higher scores reflect better health status) and subsequent all-cause mortality/hospitalization. Among 2038 patients with KCCQ data at the 3-month visit, KCCQ scores increased from baseline by ≥5 points for 45%, scores decreased by ≥5 points for 23%, and scores changed by <5 points for the remaining 32% of patients. There was a non-linear relationship between change in KCCQ and outcomes. Worsening health status was associated with increased all-cause mortality/hospitalization (adjusted hazard ratio 1.07 per 5-point KCCQ decline; 95% confidence interval 1.03-1.12; P < 0.001). In contrast, improving health status, up to an 8-point increase in KCCQ, was associated with decreased all-cause mortality/hospitalization (adjusted hazard ratio 0.93 per 5-point increase; 95% confidence interval 0.90-0.97; P < 0.001). Additional improvements in health status beyond an 8-point increase in KCCQ was not associated with all-cause death or hospitalization (P = 0.42).
CONCLUSION: In patients with heart failure, small changes in KCCQ are associated with changing future risk, but more research will be necessary to understand how different magnitudes of improving health status affect outcomes.
© 2018 The Authors. European Journal of Heart Failure © 2018 European Society of Cardiology.

Entities:  

Keywords:  Health status; Patient-reported outcomes; Quality of life

Mesh:

Year:  2018        PMID: 30168635      PMCID: PMC6333485          DOI: 10.1002/ejhf.1299

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  26 in total

1.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

2.  Monitoring clinical changes in patients with heart failure: a comparison of methods.

Authors:  John Spertus; Eric Peterson; Mark W Conard; Paul A Heidenreich; Harlan M Krumholz; Philip Jones; Peter A McCullough; Ileana Pina; Joseph Tooley; William S Weintraub; John S Rumsfeld
Journal:  Am Heart J       Date:  2005-10       Impact factor: 4.749

3.  Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study.

Authors:  Inger Ekman; Olivier Chassany; Michel Komajda; Michael Böhm; Jeffrey S Borer; Ian Ford; Luigi Tavazzi; Karl Swedberg
Journal:  Eur Heart J       Date:  2011-08-29       Impact factor: 29.983

4.  Reliability and validity of the Kansas City cardiomyopathy questionnaire in patients with previous myocardial infarction.

Authors:  Kjell I Pettersen; Aasmund Reikvam; Arnfinn Rollag; Knut Stavem
Journal:  Eur J Heart Fail       Date:  2005-03-02       Impact factor: 15.534

5.  The effects of antihypertensive therapy on the quality of life.

Authors:  S H Croog; S Levine; M A Testa; B Brown; C J Bulpitt; C D Jenkins; G L Klerman; G H Williams
Journal:  N Engl J Med       Date:  1986-06-26       Impact factor: 91.245

6.  Health-related quality of life among patients undergoing percutaneous transluminal coronary angioplasty.

Authors:  P D Cleary; A M Epstein; G Oster; G S Morrissey; W B Stason; S Debussey; J Plachetka; M Zimmerman
Journal:  Med Care       Date:  1991-10       Impact factor: 2.983

7.  Prognostic value of health status in patients with heart failure after acute myocardial infarction.

Authors:  Gabriel E Soto; Philip Jones; William S Weintraub; Harlan M Krumholz; John A Spertus
Journal:  Circulation       Date:  2004-07-19       Impact factor: 29.690

8.  Quantifying clinical change: discrepancies between patients' and providers' perspectives.

Authors:  Rachel P Dreyer; Philip G Jones; Shelby Kutty; John A Spertus
Journal:  Qual Life Res       Date:  2016-03-19       Impact factor: 4.147

Review 9.  Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review.

Authors:  Jeffrey M Peppercorn; Jane C Weeks; E Francis Cook; Steven Joffe
Journal:  Lancet       Date:  2004-01-24       Impact factor: 79.321

10.  Identifying heart failure patients at high risk for near-term cardiovascular events with serial health status assessments.

Authors:  Mikhail Kosiborod; Gabriel E Soto; Philip G Jones; Harlan M Krumholz; William S Weintraub; Prakash Deedwania; John A Spertus
Journal:  Circulation       Date:  2007-04-09       Impact factor: 29.690

View more
  10 in total

1.  The association between heart failure hospitalization and self-reported domains of health.

Authors:  Gregory A Nichols; Jacqueline Pesa; Daniel S Sapp; Aarti Patel
Journal:  Qual Life Res       Date:  2019-11-28       Impact factor: 4.147

2.  Exercise-based cardiac rehabilitation in patients with reduced left ventricular ejection fraction: The Cardiac Rehabilitation Outcome Study in Heart Failure (CROS-HF): A systematic review and meta-analysis.

Authors:  Birna Bjarnason-Wehrens; R Nebel; K Jensen; M Hackbusch; M Grilli; S Gielen; B Schwaab; B Rauch
Journal:  Eur J Prev Cardiol       Date:  2019-06-08       Impact factor: 7.804

3.  Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.

Authors:  Nadia Bouabdallaoui; Eileen O'Meara; Virginie Bernier; Michel Komajda; Karl Swedberg; Luigi Tavazzi; Jeffrey S Borer; Michael Bohm; Ian Ford; Jean-Claude Tardif
Journal:  ESC Heart Fail       Date:  2019-10-08

4.  Effectiveness of Artificial Intelligence Models for Cardiovascular Disease Prediction: Network Meta-Analysis.

Authors:  Yahia Baashar; Gamal Alkawsi; Hitham Alhussian; Luiz Fernando Capretz; Ayed Alwadain; Ammar Ahmed Alkahtani; Malek Almomani
Journal:  Comput Intell Neurosci       Date:  2022-02-24

5.  Impact of Pharmacist-Led Heart Failure Clinic on Optimization of Guideline-Directed Medical Therapy (PHARM-HF).

Authors:  Tanvi Patil; Salihah Ali; Alamdeep Kaur; Meghan Akridge; Davida Eppes; James Paarlberg; Amitabh Parashar; Nabil Jarmukli
Journal:  J Cardiovasc Transl Res       Date:  2022-05-02       Impact factor: 3.216

Review 6.  Could SGLT2 Inhibitors Improve Exercise Intolerance in Chronic Heart Failure?

Authors:  Suzanne N Voorrips; Huitzilihuitl Saucedo-Orozco; Pablo I Sánchez-Aguilera; Rudolf A De Boer; Peter Van der Meer; B Daan Westenbrink
Journal:  Int J Mol Sci       Date:  2022-08-03       Impact factor: 6.208

7.  Effects of continuous aerobic training associated with resistance training on maximal and submaximal exercise tolerance, fatigue, and quality of life of patients post-COVID-19.

Authors:  Bruna T S Araújo; Ana Eugênia V R Barros; Daiara T X Nunes; Maria Inês Remígio de Aguiar; Viviane W Mastroianni; Juliana A F de Souza; Juliana Fernades; Shirley Lima Campos; Daniella Cunha Brandão; Armele Dornelas de Andrade
Journal:  Physiother Res Int       Date:  2022-09-11

Review 8.  Fatigue in Persons With Heart Failure: A Systematic Literature Review and Meta-Synthesis Using the Biopsychosocial Model of Health.

Authors:  Noelle V Pavlovic; Nisha A Gilotra; Christopher S Lee; Chiadi Ndumele; Dimitra Mammos; Cheryl Dennisonhimmelfarb; Martha AbshireSaylor
Journal:  J Card Fail       Date:  2021-07-28       Impact factor: 5.712

9.  Change of Health-Related Quality of Life Over Time and Its Association With Patient Outcomes in Patients With Heart Failure.

Authors:  Nariman Sepehrvand; Anamaria Savu; John A Spertus; Jason R B Dyck; Todd Anderson; Jonathan Howlett; Ian Paterson; Gavin Y Oudit; Padma Kaul; Finlay A McAlister; Justin A Ezekowitz
Journal:  J Am Heart Assoc       Date:  2020-08-19       Impact factor: 5.501

10.  Current challenges for using the Kansas City Cardiomyopathy Questionnaire to obtain a standardized patient-reported health status outcome.

Authors:  Nicolette Stogios; Gabriel Fezza; Julia V Wong; Heather J Ross; Michael E Farkouh; Robert P Nolan
Journal:  Eur J Heart Fail       Date:  2021-03-08       Impact factor: 15.534

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.